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The Journal of Immunology
Tissue-Specific Education of Decidual NK Cells
Andrew M. Sharkey,*,†,1 Shiqiu Xiong,*,†,1 Philippa R. Kennedy,*,† Lucy Gardner,*,†
Lydia E. Farrell,*,† Olympe Chazara,*,† Martin A. Ivarsson,*,† Susan E. Hiby,*,†
Francesco Colucci,†,‡ and Ashley Moffett*,†
During human pregnancy, fetal trophoblast cells invade the decidua and remodel maternal spiral arteries to establish adequate
nutrition during gestation. Tissue NK cells in the decidua (dNK) express inhibitory NK receptors (iNKR) that recognize allogeneic
HLA-C molecules on trophoblast. Where this results in excessive dNK inhibition, the risk of pre-eclampsia or growth restriction is
increased. However, the role of maternal, self–HLA-C in regulating dNK responsiveness is unknown. We investigated how the
expression and function of five iNKR in dNK is influenced by maternal HLA-C. In dNK isolated from women who have HLA-C
alleles that carry a C2 epitope, there is decreased expression frequency of the cognate receptor, KIR2DL1. In contrast, women
with HLA-C alleles bearing a C1 epitope have increased frequency of the corresponding receptor, KIR2DL3. Maternal HLA-C
had no significant effect on KIR2DL1 or KIR2DL3 in peripheral blood NK cells (pbNK). This resulted in a very different KIR
repertoire for dNK capable of binding C1 or C2 epitopes compared with pbNK. We also show that, although maternal KIR2DL1
binding to C2 epitope educates dNK cells to acquire functional competence, the effects of other iNKR on dNK responsiveness are
quite different from those in pbNK. This provides a basis for understanding how dNK responses to allogeneic trophoblast affect
the outcome of pregnancy. Our findings suggest that the mechanisms that determine the repertoire of iNKR and the effect of self-
MHC on NK education may differ in tissue NK cells compared with pbNK. The Journal of Immunology, 2015, 195: 3026–3032.
N
atural killer cells are lymphocytes that function in both
immune defense and in reproduction (1, 2). Tissue NK
cells differ from circulating NK cells because their
phenotype and function are modified by the local microenviron-
ment (3). NK activity is controlled by integration of signals from
activating and inhibitory receptors for stress ligands, adhesion
molecules, and polymorphic HLA class I molecules (4). These
include members of the killer cell Ig-like receptor (KIR), leuko-
cyte Ig-like receptor (LILR), and C-type lectin-like receptor
families (5, 6) Peripheral blood NK cells (pbNK) express inhibi-
tory NK cell receptors (iNKR) stochastically, resulting in diverse
NK subsets within an individual (7, 8). The uterine mucosa
contains abundant uterine NK cells, present in the nonpregnant
luteal phase and the first half of pregnancy. They are CD56bright
CD162NKG2A+ with low cytoxicity and are functionally and
phenotypically distinct from both CD56bright and CD56dim sub-
sets in pbNK (9–11). A unique feature of decidual NK cells
(dNK) is that in pregnancy they are exposed to maternal as well
as paternally inherited, allogeneic HLA-C molecules on fetal
trophoblast cells (12).
During early placental development, extravillous trophoblast
cells (EVT) from the fetus invade into the decidua and remodel
maternal spiral arteries to ensure sufficient blood supply to the
developing fetus (13). Reduced trophoblast invasion is associated
with major complications of pregnancy, including fetal growth re-
striction and pre-eclampsia (14). EVT express a unique array of
MHC class I molecules: HLA-C, HLA-E, and HLA-G, but not
HLA-A or HLA-B (15–17). dNK express receptors for these tro-
phoblast HLA class I molecules and are thus potentially capable
of mediating allorecognition of the fetus. Additionally, dNK can
bind HLA on surrounding maternal cells. For example, most dNK
(95%) express inhibitory CD94/NKG2A, which can bind HLA-E
on fetal EVT as well as maternal cells (18). LILRB1, expressed by
∼40% of dNK, is an inhibitory receptor for all HLA class I
molecules but has a much higher affinity for the dimeric form of
HLA-G on EVT (19, 20). Expression of KIR in dNK is also dif-
ferent from expression in pbNK, and the HLA-C–binding KIR
show increased expression frequencies in dNK (21).
We have previously demonstrated that some of these maternal
NKR–fetal ligand interactions operate in the decidua (12, 15, 19).
KIR interactions with HLA-C molecules are of particular interest
because KIR can be inhibitory or activating and both KIR and
HLA-C are highly polymorphic (22). Each pregnancy is charac-
terized by different combinations of maternal KIR and fetal
HLA-C genes, resulting in variable dNK inhibition or activation.
Women homozygous for the KIR A haplotype are at increased
risk of pregnancy disorders when the fetus has an HLA-C allele
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carrying a C2 epitope (C2), a combination that will functionally
result in strongly inhibitory signals to uterine NK cells (12, 23,
24). Conversely, the KIR B haplotype, which includes activating
KIR2DS1 that binds C2 ligands, is associated with protection
from pre-eclampsia and increased birth weight (12, 25). Ligation
of KIR2DS1 by C2 stimulates secretion of cytokines, including
GM-CSF, which enhances primary trophoblast migration in vitro,
suggesting a mechanism for the protective effect of KIR2DS1 (26).
These genetic and functional data show that dNK activation can
be regulated by C2 epitopes on EVT to influence placental devel-
opment. The weaker inhibitory interaction between KIR2DL3 and
fetal C1 appears to have no significant effect on pregnancy outcome,
emphasizing the importance of KIR2DL1 and fetal C2. However,
dNK proliferate in the uterine microenvironment and it is not
known how maternal HLA class I expression affects their educa-
tion and potential to respond. NK cell education depends on
interactions between iNKR and MHC class I molecules that fine-
tune NK responsiveness so that stronger inhibition during NK mat-
uration leads to more potent NK cells (27–29). In a situation where
there is loss of self–MHC class I molecules, as in viral infection,
education allows these highly responsive NK cells to detect the altered
self. Individuals homozygous for the KIR A haplotype possess pre-
dominantly inhibitory KIR, including KIR2DL1 that binds strongly to
C2 ligands. It follows that these individuals might have an advan-
tage in surviving infection as well as cancer, as they will have more
potent NK cells, especially if they also have C2-bearing allotypes.
Do these concepts translate into the situation at the maternal/
fetal interface in utero? Evidence in mice suggests that dNK
education is imparted by maternal, not paternal, MHC class I
molecules (30). This is supported by genetic findings in humans
where women who have a KIR AA genotype and a fetus with a
paternal C2 ligand are at greater risk of pre-eclampsia than when
the fetal C2 is derived from the mother (12). The presence of ma-
ternal C2 appears protective. In pbNK, the presence of the C1 or C2
epitope affects the function of NK cells expressing the cognate KIR,
and it may also affect their frequency of KIR expression, but
whether this is true in dNK is unknown (8, 28). NKG2A and
LILRB1 can also bind EVTand so may modify the function of dNK
through education and during the effector phase. The frequency and
distribution of expression of iNKR on dNK are variable and how
this modifies functions regulated by KIR/HLA-C interactions is not
known. Understanding how maternal and fetal HLA molecules in-
teract with iNKR would enhance our ability to predict high-risk
pregnancies. In this study, we have analyzed the expression of
five iNKR that bind HLA class I molecules and compared how
these regulate the function of specific subsets of dNK and pbNK.
Our data reveal fundamental differences in how maternal iNKR are
influenced by self–HLA class I molecules to regulate the pheno-
type, education, and responsiveness of dNK compared with pbNK.
Materials and Methods
Primary cells and tissue
Protocols using human tissue were approved by the Cambridge central
Research Ethics Committee (study 04/Q0108/23). Informed written con-
sent was obtained from all donors. Total decidual leukocytes (DL) were
isolated by enzymatic digestion of maternal decidual tissue from donors
undergoing elective termination between 7 and 12 wk of pregnancy, as
described previously (10). PBMC were isolated by density centrifugation
using Lymphoprep (Axis-Shield) from fresh venous blood obtained at the
same gestational age. Genomic DNA for KIR and HLA-C typing was
isolated from purified cells using the QIAmp kit (Qiagen).
Genotyping of KIR and HLA-C
KIR and HLA-C were typed from genomic DNA by PCR with sequence-
specific primers for their presence or absence as described previously
(24). KIR genes typed were 3DL1, 3DS1, 2DL1, 2DL2, 2DL3, 2DL5,
2DS1, 2DS2, 2DS3, 2DS4, 2DS5, and 2DP1. Typing for HLA-C was
performed using a similar approach, which allowed all known HLA-C
group C1 alleles to be distinguished from C2 alleles.
Flow cytometry
Fresh PBMC or decidual cells were washed and resuspended in 100 ml
FACS buffer (PBS, 1% FCS) and incubated with 5 mg human g-globulins
(Sigma-Aldrich) for 15 min to block nonspecific binding. Staining with
directly conjugated Abs to surface markers was performed for 25 min at
4˚C. Abs were CD56 (clone HCD56, BV421, BioLegend), CD3 (UCHT1,
allophycocyanin-Cy7, BioLegend) and CD9-PerCP-Cy5.5 (M-L13, PerCP,
BD Pharmingen), KIR2DL1 (143211, FITC, R&D Systems), NKG2A
(Z199, allophycocyanin, Beckman Coulter), KIR2DL3/L2/S2 (GL183, PE-
Cy7, Beckman Coulter), CD122 (Tu27, APC, BD Biosciences), and
LILRB1 (HP-F1, PE, Beckman Coulter). For some donors KIR2DL3 alone
was stained using clone 180701 (R&D Systems). KIR3DL1 was stained
with DX9 conjugated to biotin (BioLegend). Cells were washed with
FACS buffer twice followed by staining the near-IR fixable Live/Dead cell
dye (Invitrogen) and biotinylated Ab was detected with streptavidin Qdot-
605. After washing in FACS buffer, cells were and fixed in 2% parafor-
maldehyde. For intracellular Ags, cells were treated with FIX & PERM
(Life Technologies) and stained for Ki67 (B56, PerCP-cy5.5, BD Bio-
sciences) or c-Myc (9E10, Alexa647, AbD Serotec). Samples were run on
an LSRFortessa FACS analyzer (BD Biosciences) and data were analyzed
using FlowJo (Tree Star).
Functional assays
For functional assays, preparations of DL or PBMC were recovered
overnight in RPMI 1640 medium, antibiotics, 10% FCS, and 2.5 ng/ml
IL-15 (PeproTech). This low dose of IL-15 maintains NK viability with-
out significant activation. DL preparations (.50% dNK) with ,5% pbNK
contamination (CD56+CD92) were used in functional assays. The edu-
cation status of NK cells was assessed by incubation of 2 3 105 dNK per
well with K562 cells for 5 h at an E:T ratio of 5:1. GolgiStop at 6 mg/ml
(BD Biosciences) was added for the last 4 h of the incubation. Degranu-
lation was assessed by staining with anti-CD107a in the PerCP-Cy5.5
channel (clone H4A3, BioLegend) when staining dNK subsets as de-
scribed above.
Statistical analysis
The Wilcoxon signed rank test was used to compare two groups of paired
data, and the Mann–Whitney U test was used for comparison of groups
of nonpaired data. A nonparametric Friedman ANOVA was used to test
for differences between multiple KIR2DL1+ subsets with different
iNKRs. A p value ,0.05 was considered statistically significant. Cor-
relation between CD122 and c-Myc expression in dNK subsets was
tested by calculating the Spearman rank correlation coefficient.
Results
Maternal HLA-C genotype affects the frequencies of
KIR2DL1+ and KIR2DL3+ dNK
dNK express an unusual repertoire of iNKR compared with their
blood counterparts. We used nine-color flow cytometry to exam-
ine the expression of selected iNKR (KIR2DL1, KIR2DL3/L2/S2,
KIR3DL1, LILRB1, and NKG2A) in samples of freshly isolated
dNK and pbNK (Fig. 1A). As previously reported (21), the fre-
quency of KIR2DL1+ and KIR2DL3/L2/S2+ dNK is increased
compared with pbNK, whereas KIR3DL1 is similar (Fig. 1B).
NKG2A is expressed on .90% of dNK compared with 48% of
pbNK. Expression of LILRB1 is similar for pbNK (mean, 37%;
range, 4–79%) and dNK (mean, 43%; range, 8–85%). Analysis
of matched pairs of pbNK and dNK from the same donor gave
similar results (Supplemental Fig. 1). We examined whether the
overall frequency of dNK expressing KIR2DL1 or KIR2DL3
was affected by the mother’s HLA-C genotype. The frequency of
KIR2DL1+ dNK was significantly decreased in mothers with at
least one C2 epitope, the ligand for KIR2DL1 (mean, 31%; range,
4.2–74%) compared with those who were homozygous C1/C1
(mean, 40%; range, 5–82%; Fig. 1C). In contrast, the frequency
of KIR2DL3+ dNK was increased in C1/X (mean, 55%; range,
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24–81%) compared with C2/C2 mothers (mean, 41%; range, 23–
62%; Fig. 1C). Maternal HLA-C status had no significant effect
on frequency of KIR2DL1 or KIR2DL3 in pbNK. Thus, unlike
in pbNK, the presence of maternal C1 or C2 ligands has differ-
ent effects on overall frequencies in dNK of their corresponding
receptors, KIR2DL1+ or KIR2DL3+. Because dNK may encounter
invading EVT in decidua, we asked whether the presence of fetal
C2 on trophoblast influenced overall KIR2DL1 frequency. Fetal
HLA-C genotype had no significant effect (Supplemental Fig. 4).
Decidual NK cells expressing multiple inhibitory NK receptors
proliferate in the decidua
We next compared the repertoire of KIR2DL1+ and KIR2DL3+
cells between matched dNK and pbNK samples from 21 donors
by analyzing the expression patterns of these five iNKR. This
allows quantification of 32 distinct NK subsets, producing a
characteristic “fingerprint” for pbNK and dNK from each donor
(Fig. 2A). Although the repertoires from each individual are dif-
ferent, the dNK repertoire has distinctive common features. Al-
though most dNK are NKG2A+, an equal proportion of pbNK and
dNK express NKG2A without other iNKR (∼25%). Notably, 44%
of dNK express three or more iNKR compared with only 8.3% of
pbNK (Fig. 2B). This dramatic increase is due to expansion of
dNK subsets that are KIR2DL3+NKG2A+ and not simply the
higher overall frequency of NKG2A+ dNK (Fig. 2A, Supplemental
Fig. 2). The frequency of Ki-67+ cells in each dNK subset also
increases as the number of iNKR rises, suggesting dNK subsets
with multiple iNKR expand due to enhanced proliferation (Fig.
2C, 2D). IL-15, a potent mitogen for dNK, is produced by
decidualized stroma (31, 32). Intensity of staining for both
CD122 (a component of the IL-15 receptor) and c-Myc (a down-
stream target of IL-15) correlates with Ki-67 staining, implying
that dNK subsets with more iNKR expand because of increased
sensitivity to IL-15 (Fig. 2D, 2E). Overall, the data suggest clear
differences in the effect of maternal HLA-C on the percentage of
dNK and pbNK expressing KIR2DL1 or KIR2DL3.
Decidual NK cells are educated by maternal HLA-C molecules
Our genetic findings point to the pivotal role of interactions be-
tween maternal KIR2DL1 and fetal C2 epitopes in regulating
reproductive success. In contrast, in pregnancies with a C1/C1
fetus, outcomes are independent of KIR genotype. We next asked
whether the responsiveness of KIR2DL1+ dNK depends on edu-
cation by maternal HLA-C molecules. We used staining for
CD107a to measure degranulation of KIR2DL1+ dNK in response
to the HLA class I2 target cell, K562. This is a robust assay used
to measure NK education in human pbNK, which also allows
direct comparison of dNK and pbNK (28). In line with previous
reports, KIR2DL1+ pbNK show increased CD107 degranulation in
response to K562 in subsets expressing multiple iNKR (Fig. 3A).
This reflects the increased education status of NK cells expressing
multiple iNKR for self–HLA class I molecules. In contrast, de-
granulation of KIR2DL1+ dNK was lower than for the corre-
sponding pbNK subset and showed no increase with the number of
additional iNKR expressed (Fig. 3A; see Supplemental Fig. 3 for
all 32 subsets). To determine whether KIR2DL1 can educate dNK,
we compared degranulation of dNK from mothers homozygous
for HLA-C1 alleles (C1/C1) to those with at least one HLA-C2
allele (C2/X). KIR2DL1 single-positive dNK (KIR2DL1sp)
degranulated more vigorously when the mother was C2/X, con-
firming that maternal C2 epitopes can educate KIR2DL1sp dNK
cells as for pbNK (Fig. 3B). Coexpression of KIR2DL1 and
NKG2A enhanced degranulation in both dNK and pbNK and pre-
served the education effect mediated through KIR2DL1 and HLA-
C2. In contrast to pbNK, when dNK coexpress KIR2DL1 with
either LILRB1 or KIR3DL1, the educating effect of KIR2DL1 was
lost (only data for LILRB1 is shown) Fig. 3B). We also studied
whether these educating effects are additive by analyzing hetero-
zygous C1/C2 donors, where education can occur through both
KIR2DL1 and KIR2DL3/L2. Degranulation was enhanced in
pbNK that coexpressed KIR2DL1 and other iNKR, but not in
dNK (Fig. 3C). We conclude that the reduced responsiveness of
dNK in subsets expressing multiple NKR occurs because, unlike
pbNK, coeducation does not take place.
The effect of iNKR on NK responsiveness differs between dNK
and pbNK
We then determined how NKG2A or LILRB1 modulate re-
sponses of all 32 NK subsets in C1/C2 donors. In pbNK, NKG2A
FIGURE 1. dNK show selective upregulation of specific iNKR compared
with pbNK. (A) Freshly isolated lymphocytes from decidua or peripheral
blood from the same donor were gated on live CD56+CD32 cells and ex-
amined for expression of KIR2DL1, KIR2DL3, KIR3DL1, LILRB1, and
NKG2A. (B) Overall frequency of CD56+CD32 NK cells positive for the
selected iNKRs in samples from blood (s) and decidua (d), expressed as
a percentage of total NK cells (n = 53 and 61 for pbNK and dNK, respec-
tively). (C) Effect of maternal HLA-C1 or -C2 alleles on overall frequency
of expression of KIR2DL1 and KIR2DL3 was determined by stratifying
donors from (B) according to the maternal HLA-C type. C1/C1 indicates
donor had two C1 alleles; C2/X indicates either C2/C1 or C2/C2 genotype.
Frequency of 2DL3+ NK cells was determined in pbNK (n = 24) and dNK
(n = 34) by staining with mAb GL183 in patients who were genotyped as
KIR2DL22KIR2DS22. C1/X indicates donor genotype was either C1/C1 or
C1/C2. Horizontal bars indicate the mean percentage, and symbols indicate
individual samples. *p , 0.05, **p , 0.001, Mann–Whitney U test.
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has a strong educating effect and all NKG2A+ subsets show
enhanced responses to K562, compared with the correspond-
ing NKG2A2 subset, regardless of how many other iNKR are
coexpressed (Fig. 4A). The effect of NKG2A on dNK is more
complex. For subsets that express a single additional iNKR,
NKG2A enhances responsiveness, but this effect is lost in dNK
expressing multiple iNKR. For LILRB1, the opposite effect is
observed; coexpression of LILRB1 in subsets with a single
iNKR decreases the responses of dNK and the effect persists in
subsets with more iNKR. Degranulation of pbNK subsets was
unaffected by coexpression of LILRB1 as previously reported
(8) (Fig. 4B). In summary, dNK are educated through the in-
teraction of maternal HLA-C with KIR2DL1 and education by
NKG2A can enhance these responses. However, unlike pbNK,
where LILRB1 has no significant effect, LILRB1 downregulates
responses of dNK subsets in which it is expressed and this can
overcome any educating effect of KIR2DL1 or NKG2A. Taken
together, these results show that dNK differ significantly from
pbNK in the way iNKR regulate overall responsiveness.
Discussion
Pregnancy is unique in that the degree of dNK inhibition depends
on both maternal and fetal HLA. Interactions between maternal
dNK and fetal HLA-C that result in excessive dNK inhibition are
associated with an increased risk of pregnancy complications (12,
23, 24). In this study, we have examined the distribution of five
major inhibitory NKR for HLA class I molecules on dNK and
analyzed how maternal HLA-C regulates their function. We find
there are major differences in how maternal HLA class I mole-
cules regulate dNK responsiveness compared with pbNK, through
effects both on the iNKR repertoire and education of dNK.
The primary determinant of iNKR expression in pbNK is ge-
netic. Stochastic promoter regulation leads to an NK cell reper-
toire with thousands of subsets that can differ even between
FIGURE 2. Expansion of specific iNKR sub-
sets in decidual NK cells compared with matched
pbNK. The expression of KIR2DL1, KIR2DL3/
L2/S2, KIR3DL1, LILRB1, and NKG2A was
examined by nine-color flow cytometry in
matched pbNK and dNK from 21 donors. (A)
Thirty-two distinct NK subsets were distin-
guished on the basis of the five iNKR in paired
samples of pbNK and dNK (black and red
graphs, respectively). The frequency of each
subset from one representative donor is shown
as a percentage of total NK cells. This provides
a “fingerprint” of the iNKR repertoire, which is
characteristic for each donor. The receptor com-
bination for each subset is denoted by black-
filled circles, with total number of iNKR in
each subset indicated beneath. All NKG2A+
subsets are grouped to the right. The donor
shown was genotyped as C1/C1. (B) The pro-
portion of pbNK and dNK that express specific
receptor combinations is shown as a percent-
age of total NK cells (mean 6 SD, n = 21
matched pbNK and dNK pairs). The proportion
of dNK that express two or more iNKR is sig-
nificantly higher than in pbNK. (C) The per-
centage of dNK cells that are positive for Ki-67
was determined in each iNKR subset by intra-
cellular staining. Control staining used isotype-
matched mAb. The NK cells shown were gated
on total KIR2DL1+ dNK as shown in Fig. 1A.
(D) The percentages of dNK that are positive
by intracellular staining for Ki-67 (d) and for
CD122 (▴) are shown for all NKG2A+ dNK
subsets (mean for each subset indicated by d or
▴ 6 SD, derived from n = 11 donors). (E) Mean
fluorescence intensity (MFI) of staining of each
subset is shown following staining for CD122
and c-Myc in the NKG2A+ dNK subsets from
(D). For each donor, MFI of each subset was
expressed relative to the subset expressing
NKG2A alone, which was set at 100%. Relative
MFI of CD122 and c-Myc is highly correlated
(Spearman rank correlation coefficient, R2 =
0.84, p , 0.001).
The Journal of Immunology 3029
 at Cam
bridge U
niversity Library on M
arch 23, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
monozygotic twins (33, 34). KIR gene copy number, host HLA
status, and viral infection can impose further changes, including
expansion of specific NK subsets (7, 35). The factors determining
the repertoire of HLA-binding iNKR in NK cells residing in hu-
man tissues (as opposed to blood) remain poorly understood. Our
data suggest that selective expansion of certain subsets may
contribute to the tissue-specific repertoire seen in dNK. Ki-67
frequency and staining intensity for CD122, the b-chain of the
IL-15 receptor, were highest on subsets with multiple iNKR,
which also showed upregulation of c-Myc. Higher CD122 may
increase sensitivity to IL-15, a cytokine that stimulates vigorous
dNK cell division and acquisition of KIR (36, 37). Selective ex-
pansion of dNK subsets that coexpress KIR2DL3 and NKG2Awas
also found, but because these subsets did not show increased
CD122, other mechanisms must regulate their expansion.
When donors were stratified based on the presence of C1 or C2
epitopes, we found that KIR2DL1 frequency was significantly
decreased in dNK in C2 mothers whereas KIR2DL3 increased
in dNK in mothers with C1. This contrasts with pbNK, where
some studies have reported increased expression of KIR2DL1 in
pbNK of C2 individuals, whereas others have found no effect (38–
40). We found no evidence that fetal HLA-C genotype affected
KIR in dNK. Why KIR2DL1 and KIR2DL3 frequencies in dNK
should be differently affected by their maternal HLA ligands is
not clear. The reduction in frequency of KIR2DL1+ dNK by
maternal C2 epitopes could be an evolutionary adaptation to re-
duce risk in pregnancies where the chance of an HLA-C2 fetus is
at least 50% and help to maintain HLA-C alleles with C2 epitopes
in the human population (22).
Because the overall inhibition experienced by dNK appears to
regulate placentation, a key aim of this study was to determine
how the main iNKRs for HLA class I molecules regulate dNK
responsiveness. KIR2DL1 has previously been shown to educate
pbNK through C2, and we show in the present study that KIR2DL1
FIGURE 3. dNK are educated differently
by iNKR compared with pbNK. (A) Degranu-
lation was measured by CD107a staining of
32 separate NK subsets from pbNK (s) and
dNK (d), following coculture with K562 cells
(n = 28 and 35, respectively). Only KIR2DL1+
subsets are shown (see Supplemental Fig. 3
for all 32 subsets). Subsets were defined by
expression of five selected iNKRs as described
in Fig. 1A. Frequency of CD107a+ cells is the
percentage of NK cells in that subset that stain
positive for CD107a (mean 6 SD). Donors
were not stratified according to HLA-C geno-
type. (B) Effect of donor’s HLA-C genotype on
degranulation in pbNK and dNK in response
to K562 was compared between donors strati-
fied according to the maternal HLA-C geno-
type. C1/C1 indicates donor homozygous for
C1 group; C2/X indicates C1/C2 or C2/C2.
Subsets shown are KIR2DL1sp, KIR2DL1+
NKG2A+, and KIR2DL1+LILRB1+. **p ,
0.01, Mann–Whitney U test. Bar shows mean.
(C) Effect of multiple iNKR on degranulation
in response to K562 in pbNK (n = 12) and
dNK (n = 14) from C1/C2 donors where both
KIR2DL1 and KIR2DL3/L2 will have a ma-
ternal HLA-C ligand (d, receptor present on
subset). There was a statistically significant
difference in degranulation with increasing
iNKR on each subset. **p , 0.001 for both
pbNK and dNK, Friedman nonparametric
ANOVA.
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also educates dNK upon interaction with maternal C2 (28, 41).
Owing to the scarcity of relevant donors, we were unable to de-
termine whether dNK are also educated by KIR2DL3 binding to
maternal C1 epitopes. Collection of sufficient KIRAA mothers
with C2/X or C1/C1 genotypes is ongoing. dNK proliferate vig-
orously in the decidua while expressing a full complement of
KIR and NKG2A. Because these freshly produced dNK are edu-
cated by HLA-C, this suggests that adaptation to the maternal
HLA environment takes place locally in the decidual tissue. These
findings are similar to those in the mouse where maternal but not
paternal MHC ligands educate NK cells in the decidua (30).
An important finding is that there are major differences in
how iNKR combine to regulate responsiveness of dNK com-
pared with pbNK. In pbNK, NKG2A is a strong educating
iNKR, and all NKG2A+ subsets degranulate more vigorously in
response to K562 than does the corresponding subset without
NKG2A (8). In dNK the effect of NKG2A was more complex.
NKG2A maintained the educational effects of KIR2DL1 to
maternal C2, but in subsets expressing additional iNKR, re-
sponses were decreased. In contrast, LILRB1 had little effect
on pbNK responsiveness, but in all dNK subsets it abolished the
educational effects of KIR2DL1 and decreased responsiveness.
This may be due to the greatly increased avidity of binding of
LILRB1 to the dimeric form of HLA-G found on EVT, because
other LILRB1/HLA interactions remain similar in pbNK and
dNK (19). In pbNK we find that as the number of educating
iNKRs on the subset increases, responsiveness goes up due to
additive effects of education, in agreement with previous
reports (8, 42). In dNK the reverse is true; responsiveness
decreases in subsets with more “educating” iNKR. The overall
effect of interactions between KIR, NKG2A, and LILRB1 is
that dNK degranulation in response to K562 remains similar
regardless of the number of iNKR. We conclude there are
fundamental differences in the ways that iNKR educate indi-
vidual subsets in pbNK and dNK. A limitation of this study is
that dNK responsiveness was assessed by degranulation alone.
Whether secretion of cytokines by dNK is similarly affected by
NKR remains to be determined, but in pbNK the effects of NKR
on degranulation and IFN-g secretion were similar (8, 28).
Few studies have examined the repertoire and functions of
inhibitory MHC receptors in NK cells from nonlymphoid hu-
man tissues. Although heterogeneous, NK cells in other human
tissues share some characteristics of dNK. They tend to be
CD56bright, NKG2A+, produce a variety of cytokines, and are
less cytotoxic than pbNK (3). In the liver ∼50% of the NK cells
are NKG2A+, and they are educated by KIR that bind self-HLA
(43). In fetal tissues, up to 90% of NK cells are NKG2A+. Fetal
NK cells are educated by NKG2A but not by KIR binding to
self-HLA; instead, KIR+ fetal NK cells are hyporesponsive (44).
Our finding that some dNK are more responsive when they are
NKG2A+ suggests that this NKR may also educate NK cells in
the decidua, but the educating effect was not seen in all subsets
(Fig. 4A). An alternative explanation is that NKG2A does not
educate dNK but is a marker for more activated NK cells in
decidua. However, all dNK are CD69+,so there is currently no
evidence for differential activation among dNK subsets (10).
These studies emphasize that the functional consequences of
iNKR interactions with the cognate HLA ligands in primary NK
cells are likely to be tissue specific. Predicting effects of specific
iNKR–HLA interactions on repertoire and NK function based on
results from pbNK may be misleading. This is particularly rele-
vant as clinical trials begin with mAbs targeting iNKR.
Our genetic findings in several cohorts indicate that the key
effects of HLA-C in pregnancy are mediated by KIR that recog-
nize C2 epitopes (12, 23–25). The interaction between KIR2DL3
and fetal C1 appears to have no significant effect on pregnancy
outcome. The contrasting effect of maternal HLA-C on KIR2DL1
and KIR2DL3 expression in this study highlights their different
roles in placentation. In the present study, we have shown that
dNK functionally adapt to the presence of maternal C2 though
education in the decidua as well as by reducing the frequency of
cells expressing KIR2DL1. Both findings suggest mechanisms
whereby maternal HLA-C2 can modify the risk of abnormal
placentation in KIR AA mothers with an HLA-C2 fetus (12, 24).
However, how education by maternal C2 actually alters dNK
function in a manner beneficial to pregnancy remains to be
elucidated. Finally, we have also shown that there are significant
differences in how KIR2DL1 and other iNKR combine to edu-
cate NK cells in decidua compared with pbNK. Whether these
differences in education of NK cells occur in other tissues will
clearly be important in understanding NK function in diseases
such as cancer.
FIGURE 4. NKG2A and LILRB1 have different effects
on responses of pbNK and dNK subsets. (A) Effect of
presence or absence of NKG2A on degranulation was
measured by CD107a staining of 32 separate NK subsets
in pbNK and dNK following coculture with K562 cells
(n = 12 and 14, respectively; all donors genotyped as
C1/C2). Subsets were defined as described in Fig. 1A.
Average frequency of CD107+ cells is the percentage of
the total NK cells in that subset that stain positive for
CD107a (mean 6 SD). The response of each subset lacking
NKG2A expression (d) is compared with the correspond-
ing subset expressing NKG2A (s). (B) The same analysis
was performed to compare degranulation of subsets with
(s) and without (d) LILRB1 in both pbNK and dNK.
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